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Expanding the Treatment Window Raising the Bar for Patient Safety
Claranne Mathiesen, MSN, RN, CNRN

Lehigh Valley Health Network, Allentown, Pennsylvania

Abstract:

As evidenced-based stroke care continues to evolve more alternatives
are available to enable life-saving intervention for acute ischemic stroke
patients. This presents new challenges in providing the best plan of care
which now extends beyond FDA approved intravenous alteplase to include
mechanical interventions that further extends the treatment time. Nurses
play a pivotal role in all phases of care and therefore need to gain a deeper
understanding in the decision making in the first twenty four hours. This
poster will review the current use of imaging to guide and support clinical
intervention and clarify differences between treatment time windows for
acute ischemic stroke. As important as early treatment, careful oversight
of performance criteria ensures safe delivery of care and facilitates
achievement of best patient outcomes. Participants will analyze quality
metrics to aide in the concurrent and retrospective evaluation of stroke
patient care.

Objectives:

Use of Imaging to Guide Clinical Decisions:

Computed Tomography:
Non Contrast CT remains the “gold standard”in acute ischemic stroke.
Multi modality CT with CT perfusion/ CT angiography can provide info on
cerebral blood volume, blood flow and mean transit time helping to identify
ischemic core and penumbra.
Magnetic Resonance Imaging:
Earliest evidence of ischemic injury and evaluates extracranial and intracranial
blood vessels. Use of diffusion weighted and perfusion weighted imaging
provides further advantages of defining ischemic area and hemodynamic
status of cerebral blood flow. Tissue mismatch can be utilized to identify
salvageable brain.
Carotid duplex scanning used to screen for cervical internal carotid
artery stenosis.
Cerebral arteriography is the best tool to definitively evaluate the
cerebral vasculature for stenosis and changes in blood flow dynamics.
Tissue Status:

Perfusion Status:

Vessel Status:

•	Identify the inclusion/exclusion criteria for use of intravenous alteplase.
•	Apply data available from multi modality imaging and advanced endovascular
techniques to provide acute stroke rescue.

•	Warnings: Age > 80
•	NIH Stroke Scale > 25
•	Previous history of stroke and diabetes
•	Any anticoagulant use even if INR < 1.7
• CT findings consistent > 1/3 MCA territory

• Develop standard work processes
•	Advocate use of checklists
•	Annual Staff Training/In-service
•	Mock stroke drills
•	Time out before drug administration & procedures
•	Adhere to guidelines
•	Frequent monitoring before, during and after changes
•	Focused performance improvement
•	Collect and feed forward process and outcome data

Nursing Implications for Practice:

Stroke treatment is rapidly changing. Nurses need to understand
cerebrovascular pathophysiology and available options for reperfusion
interventions. Advances in neuro imaging will aide in better
patient selection for emerging new therapies with goal to open
blood vessels faster. Clear communication is essential and
includes hand offs, medication reconciliation, nurse to nurse
neuro exams and individualized plans of care.

•	Describe the decision making in extending the window for intravenous alteplase.

Summary of
Differences from FDA
Recommendations

Strategies for Best Practice:

Major Inclusion and Exclusion Criteria
Main Inclusion criteria
Acute ischemic stroke

References:

Age, 18 to 80 years
Onset of stroke symptoms 3 to 4.5 hours before initiation of study-drug administration
Stroke symptoms present for at least 30 minutes with no sigificant improvement before treatment
Main exclusion criteria
Intracranial hemorrhage
Time of symptom onset unknown
Symptoms rapidly improving or only minor before start of infusion
Severe stroke as assessed clinically (e.g. NIHSS score >25) or by appropriate imaging techniques*
Seizure at the onset of stroke
Stroke or serious head trauma within the previous 3 months
Combination of previous stroke and diabetes mellitus

Commonly Measured Acute Stroke Metrics:
NINDS Time Targets for Organized Triage of
Acute Stroke Patients: Key Evaluation Time
Targets for the Potential rtPA Candidate
Maximum Intervals Recommended by NINDS

Performance Measures From the Joint Commission
Primary Stroke Center Certification Program

Time

Stroke-1

Deep vein thrombosis prophylaxis

Administration of heparin within the 48 hours preceding the onset of stroke, with an activated partialthromboplastin time at presentation exceeding the upper limit of the normal range

Door-to-doctor first sees patient

10 min

Stroke-2

Discharged on antithrombotic therapy

Platelet count of less than 100,000 per cubic millimeter

Door-to-CT completed

25 min

Systolic pressure greater than 185 mm Hg or diastolic pressure greater than 110 mm Hg or aggressive treatment
(intravenous medication) necessary to reduce blood pressure to these limits

Stroke-3

Patients with atrial fibrillation receiving anticoagulation therapy

Door-to-CT read

45 min

Stroke-4

Thrombolytic therapy administered

Door-to-thrombolytic therapy starts

60 min

Stroke-5

Antithrombotic therapy by end of hospital day two

Oral anticoagulant treatment

Physician examination

15 min

Stroke-6

Discharged on statin medication

Major surgery or severe trauma within the previous 3 months

Neurosurgical expertise available*

2h

Stroke-7

Dysphagia screening

Admitted to monitored bed

3h

Stroke-8

Stroke education

Stroke-9

Smoking cessation/advice/counseling

Stroke-10

Assessed for rehabilitation

Blood glucose less than 50 mg per deciliter or greater than 400 mg per deciliter
Symptoms suggestive or subarachnoid hemorrhage, even if CT scan was normal

Other major disorders associated with an increased risk of bleeding
A severe stroke as assesed by imaging was defined as a stroke involving more than one third of the middle cerebral
artery territory. NIHSS denotes National Institutes of Health Stroke Scale in which total scores range from 0 to 42
with higher values reflecting more severe cerebral infarcts.

*Taken from Hacke et al (2008).

CT indicates computed tomography
*On-site or by transfer to another facility

*Taken from Summers et al (2009)
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